Chronic myelomonocytic leukemia in the light of the WHO proposals

oleh: Ulrich Germing, Corinna Strupp, Sabine Knipp, Andrea Kuendgen, Aristoteles Giagounidis, Barbara Hildebrandt, Carlo Aul, Rainer Haas, Norbert Gattermann, John M. Bennett

Format: Article
Diterbitkan: Ferrata Storti Foundation 2007-07-01

Deskripsi

The WHO classification moved CMML to myeloproliferative/myelodysplastic disorders, and defined CMML I and CMML II according to medullary and peripheral blast count. To confirm these proposals, we analyzed 266 patients with CMML I and 73 patients with CMML II. Median survival time was 20 months for CMML I, and 15 months for CMML II (p